Introduction
Angiotensin II, the effector of the renin angiotensin system, is important in regulation of blood pressure, vascular tone, and fluid homeostasis. Angiotensin II is produced both systemically and locally in the vessel wall by the actions of renin, which converts angiotensinogen into angiotensin I, and angiotensin converting enzyme (ACE), which cleaves angiotensin I to form angiotensin II. In addition to the vasoactive effects of angiotensin II,1 recent data suggest that angiotensin II plays an important role in various cardiovascular diseases associ ated with vascular smooth muscle cell (VSMC) growth and vessel wall inflammation such as hypertension, restenosis following interventional procedures, and atherosclerosis. For example, angiotensin II has been shown to stimulate VSMC growth,2.3 increase the ex pression of inflammatory mediators such as phospholipase A2 and NAD(P)H oxidase,4,5 and activate gene trans cription of proto-oncogenes such as c-fos.6 In addition, the importance of angiotensin II in the pathogenesis of cardiovascular disease has been supported by clinical trials with angiotensin converting enzyme inhibitors demonstrating survival benefits in congestive heart failure and myocardial infarction.8 In this review, we will focus on signal transduction mechanisms by which angiotensin II exerts these effects, emphasizing the role of tyrosine kinases.
The AT1 Receptor
The effects of angiotensin II are mediated by at least two high affinity receptors, designated AT1 receptor and AT2 receptor.9,10 Because the signal transduction path ways activated by the AT2 receptor remain unknown, this review will focus on signaling events stimulated by the AT1 receptor. Cloning of the AT1 receptor9,10 made it possible to analyze domains of the AT1 receptor required for binding angiotensin II, stimulating G protein activity, and mediating downstream signal transduction. The structure of the AT1 receptor shows that it is a member of the seven transmembrane spanning G protein-coupled receptor family. Based on its cDNA sequence, the AT1 receptor is composed of 359 amino acids with seven transmembrane domains (Fig 1) . Interactions among these domains and the corresponding intracellular loops are responsible for determining the nature of angiotensin II binding and receptor activation following binding. For example, the angiotensin II binding site appears to be the result of interactions among several of these domains, including the NH2 terminal extension, Tyr92 in the extracellular loop 1, the extracellular loop 3 (Asp278 and Asp281), Tyr292 and Tyr215 (Fig 1) .11-14 A recent site directed mutagenesis study suggests that an interaction between Asp74 and Tyr292 is critical for angiotensin II binding and AT1 receptor activation.15 The domains which are responsible for interactions between G protein and the receptor have been elucidated. 14,16,17 It has been established by site-directed mutagenesis that Asp74, a con served residue within the second transmembrane domain, is important in G-protein binding and activation,13,17 as well as the conserved residues Tyr29215 and Tyr215.18 In addition, the Asp125-Arg126-Tyr127 motif in the amino terminal region of the second cytoplasmic loop is import ant in G protein activation.17 Although the AT1 receptor is a G protein-coupled receptor and lacks intrinsic tyrosine kinase activity (in contrast to growth factor receptors such as the PDGF, FGF, and EGF receptors) the signal transduction events stimulated by angiotensin II through the AT1 receptor are similar to those activated by growth factors and cytokines. Signal events mediated by the AT1 receptor include activation of phospholipase C (PLC),19 calcium mobilization,20 activation of protein kinase C,21 protein tyrosine phosphorylation,22-24 activation of mitogen-activated protein (MAP) kinase,25,26 induction of proto-ooncogenes,6 activation of JAK/STAT pathway.27 It has been shown with tyrosine kinase inhibitors that many angiotensin II effect require tyrosine phosphory lation. For example, vessel contraction in response to both EGF and angiotensin II is inhibited by genistein,28 and angiotensin II-stimulated protein synthesis is blocked by genistein and herbimycin A.29 Because of the general importance of tyrosine phosphorylation in cell growth, inflammation and migration, recent studies have focused on defining the tyrosine kinases activated by angiotensin II.
Role of the AT1 Receptor Phosphorylation in
Signal Transduction AT1 receptor phosphorylation is thought to serve at least two functions: Receptor internalization and binding 
